Diabetic neuropathy diagnostic criteria

Revision as of 14:16, 30 November 2021 by Badgettrg (talk | contribs) (→‎Diagnostic Criteria)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Diabetic neuropathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Diabetic neuropathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Diabetic neuropathy diagnostic criteria On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Diabetic neuropathy diagnostic criteria

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Diabetic neuropathy diagnostic criteria

CDC on Diabetic neuropathy diagnostic criteria

Diabetic neuropathy diagnostic criteria in the news

Blogs on Diabetic neuropathy diagnostic criteria

Directions to Hospitals Treating Diabetic neuropathy

Risk calculators and risk factors for Diabetic neuropathy diagnostic criteria

Robert G. Badgett, M.D.[1]

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

Diagnostic Criteria

Criteria include[1]:

  • Michigan Neuropathy Screening Instrument (MNSI)
  • Neuropathy disability score (NDS)[2]
  • Toronto clinical scoring system (TCSS)[3]

References

  1. Yang Z, Chen R, Zhang Y, Huang Y, Hong T, Sun F, Ji L, Zhan S. Scoring systems to screen for diabetic peripheral neuropathy. Cochrane Database Syst Rev. 2018 Jul 30;2018(7):CD010974. doi: doi:10.1002/14651858.CD010974.pub2. PMCID: PMC6513667
  2. Calle-Pascual AL, Durán A, Benedí A, Calvo MI, Charro A, Diaz JA; et al. (2001). "Reduction in foot ulcer incidence: relation to compliance with a prophylactic foot care program". Diabetes Care. 24 (2): 405–7. doi:10.2337/diacare.24.2.405. PMID 11213900.
  3. Wang F, Zheng M, Hu J, Fang C, Chen T, Wang M; et al. (2021). "Value of shear wave elastography combined with the Toronto clinical scoring system in diagnosis of diabetic peripheral neuropathy". Medicine (Baltimore). 100 (35): e27104. doi:10.1097/MD.0000000000027104. PMC 8415960 Check |pmc= value (help). PMID 34477149 Check |pmid= value (help).

Template:WH Template:WS